The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar ...

Ozempic, chemically known as semaglutide, is now the first approved treatment in Canada for type 2 diabetes and to slow ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.

Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.